{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T15:14:08Z","timestamp":1761664448041,"version":"build-2065373602"},"reference-count":16,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reumatolog\u00eda Cl\u00ednica"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.reuma.2018.11.007","type":"journal-article","created":{"date-parts":[[2019,1,29]],"date-time":"2019-01-29T22:57:08Z","timestamp":1548802628000},"page":"447-454","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Patrones de tratamiento biol\u00f3gico en pacientes con enfermedades articulares inflamatorias. Estudio retrospectivo de 4 a\u00f1os de seguimiento"],"prefix":"10.1016","volume":"16","author":[{"given":"Juan D.","family":"Ca\u00f1ete","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Naranjo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Calvo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Ord\u00e1s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bel\u00e9n","family":"Arag\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gonzalo","family":"Nocea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Montse","family":"Roset","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Fern\u00e1ndez-Nebro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2013","author":"Fauci","series-title":"Harrison's rheumatology","key":"10.1016\/j.reuma.2018.11.007_bib0085"},{"key":"10.1016\/j.reuma.2018.11.007_bib0090","doi-asserted-by":"crossref","first-page":"e0123582","DOI":"10.1371\/journal.pone.0123582","article-title":"A comparison of disease burden in rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis","volume":"10","author":"Michelsen","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.reuma.2018.11.007_bib0095","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1136\/ard.2004.033571","article-title":"Longitudinal analysis of citrullinated protein\/peptide antibodies (anti-CP) during 5 year follow up in early rheumatoid arthritis: Anti-CP status predicts worse disease activity and greater radiological progression","volume":"64","author":"Ronnelid","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.reuma.2018.11.007_bib0100","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.reuma.2010.08.001","article-title":"Differences in the management of early and established rheumatoid arthritis","volume":"7","author":"Casta\u00f1eda","year":"2011","journal-title":"Reumatol Clin"},{"key":"10.1016\/j.reuma.2018.11.007_bib0105","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S1699-258X(05)72733-9","article-title":"en representaci\u00f3n del Grupo de Estudio de Costes Calidad de Vida en Artritis Reumatoide de la Sociedad Espa\u00f1ola de Reumatolog\u00eda. Resource utilization in a cohort of rheumatoid arthritis patients attended in rheumatology units in Spain","volume":"1","author":"Ruiz-Montesinos","year":"2005","journal-title":"Reumatol Clin"},{"key":"10.1016\/j.reuma.2018.11.007_bib0110","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S1699-258X(05)72744-3","article-title":"Grupo de estudio de Costes y Calidad de Vida en Artritis Reumatoide de la Sociedad Espa\u00f1ola de Reumatolog\u00eda Cost analysis in a cohort of rheumatoid arthritis patients managed in rheumatology units in Spain","volume":"1","author":"Ruiz-Montesinos","year":"2005","journal-title":"Reumatol Clin"},{"key":"10.1016\/j.reuma.2018.11.007_bib0115","first-page":"227","article-title":"Italian Society of Rheumatology (SIR) recommendations for performing arthrocentesis","volume":"59","author":"Punzi","year":"2007","journal-title":"Reumatismo"},{"key":"10.1016\/j.reuma.2018.11.007_bib0120","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1136\/ard.2003.010298","article-title":"Radiological outcome after four years of early versus delayed treatment strategy in patients with recent onset rheumatoid arthritis","volume":"63","author":"Van Aken","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.reuma.2018.11.007_bib0125","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1093\/rheumatology\/ker281","article-title":"Age at treatment predicts reason for discontinuation of TNF antagonists: Data from the BIOBADASER 2.0 registry","volume":"50","author":"Busquets","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.reuma.2018.11.007_bib0130","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1136\/annrheumdis-2011-200302","article-title":"Change in the discontinuation pattern of tumour necrosis factor antagonists in rheumatoid arthritis over 10 years: Data from the Spanish registry BIOBADASER 2.0","volume":"71","author":"G\u00f3mez-Reino","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.reuma.2018.11.007_bib0135","doi-asserted-by":"crossref","first-page":"R72","DOI":"10.1186\/ar1941","article-title":"Survival of TNF antagonists in spondylarthritis is better than in rheumatoid arthritis Data from the Spanish registry BIOBADASER","volume":"8","author":"Carmona","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.reuma.2018.11.007_bib0140","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1002\/art.30117","article-title":"Treatment response, drug survival, and predictors thereof in 764 patients with psoriatic arthritis treated with anti-tumor necrosis factor alpha therapy: Results from the nationwide Danish DANBIO registry","volume":"63","author":"Glintborg","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.reuma.2018.11.007_bib0145","doi-asserted-by":"crossref","first-page":"155","DOI":"10.4081\/reumatismo.2011.155","article-title":"GISEA. GISEA: An Italian biological agents registry in rheumatology","volume":"63","author":"Lapadula","year":"2011","journal-title":"Reumatismo"},{"key":"10.1016\/j.reuma.2018.11.007_bib0150","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.reuma.2011.06.005","article-title":"Duration of treatment with etanercept and motives for discontinuation in a cohort of patients with rheumatic disease","volume":"7","author":"Senabre-Gallego","year":"2011","journal-title":"Reumatol Clin"},{"key":"10.1016\/j.reuma.2018.11.007_bib0155","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/art.1780270401","article-title":"Evaluation of diagnostic criteria for ankylosing spondylitis: A proposal for modification of the New York criteria","volume":"27","author":"Van der Linden","year":"1984","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.reuma.2018.11.007_bib0160","first-page":"74","article-title":"Differing local and systemic inflammatory burden in polyarticular psoriatic arthritis and rheumatoid arthritis patients on anti-TNF treatment in clinical remission","volume":"35","author":"Ramirez","year":"2016","journal-title":"Clin Exp Rheumatol"}],"container-title":["Reumatolog\u00eda Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1699258X18302596?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1699258X18302596?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T15:00:31Z","timestamp":1761663631000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1699258X18302596"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":16,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S1699258X18302596"],"URL":"https:\/\/doi.org\/10.1016\/j.reuma.2018.11.007","relation":{},"ISSN":["1699-258X"],"issn-type":[{"type":"print","value":"1699-258X"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patrones de tratamiento biol\u00f3gico en pacientes con enfermedades articulares inflamatorias. Estudio retrospectivo de 4 a\u00f1os de seguimiento","name":"articletitle","label":"Article Title"},{"value":"Reumatolog\u00eda Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.reuma.2018.11.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Espa\u00f1a, S.L.U. and Sociedad Espa\u00f1ola de Reumatolog\u00eda y Colegio Mexicano de Reumatolog\u00eda. All rights reserved.","name":"copyright","label":"Copyright"}]}}